Symbol
stringlengths 1
5
| Security
stringlengths 2
38
| GICS Sector
stringclasses 11
values | GICS Sub-Industry
stringlengths 4
55
| CIK
int64 1.8k
2.04M
| 2022_10k_statements
listlengths 0
46
| 2023_10k_statements
listlengths 0
49
| 2024_10k_statements
listlengths 0
42
| 2022_q1_10q_statements
listlengths 0
29
| 2022_q2_10q_statements
listlengths 0
35
| 2022_q3_10q_statements
listlengths 0
26
| 2023_q1_10q_statements
listlengths 0
26
| 2023_q2_10q_statements
listlengths 0
25
| 2023_q3_10q_statements
listlengths 0
29
| 2024_q1_10q_statements
listlengths 0
30
| 2024_q2_10q_statements
listlengths 0
32
| 2024_q3_10q_statements
listlengths 0
34
| 2025_q1_10q_statements
listlengths 0
31
| 2022_q1_earnings_statements
listlengths 0
15
| 2022_q2_earnings_statements
listlengths 0
19
| 2022_q3_earnings_statements
listlengths 0
22
| 2022_q4_earnings_statements
listlengths 0
18
| 2023_q1_earnings_statements
listlengths 0
13
| 2023_q2_earnings_statements
listlengths 0
24
| 2023_q3_earnings_statements
listlengths 0
19
| 2023_q4_earnings_statements
listlengths 0
22
| 2024_q1_earnings_statements
listlengths 0
16
| 2024_q2_earnings_statements
listlengths 0
26
| 2024_q3_earnings_statements
listlengths 0
20
| 2024_q4_earnings_statements
listlengths 0
18
| 2025_q1_earnings_statements
listlengths 0
21
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MMM
|
3M
|
Industrials
|
Industrial Conglomerates
| 66,740
|
[] |
[
{
"analysis": "This directly describes the company's R&D activities and the output of those activities (new patents or trade secrets).",
"context": "The Company's products are sold around the world under various trademarks. The Company also owns, or holds licenses to use, numerous U.S. and foreign patents. The Company's research and development activities generate a steady stream of inventions that are covered by new patents or trade secrets. Patents applicable to specific products extend for varying periods according to the date of patent application filing or patent grant and the legal term of patents in the various countries where patent protection is obtained. The actual protection afforded by a patent, which can vary from country to country, depends upon the type of patent, the scope of its coverage and the availability of legal remedies in the country.",
"statement": "The Company's research and development activities generate a steady stream of inventions that are covered by new patents or trade secrets.",
"topic": "R&D"
},
{
"analysis": "This statement explicitly describes 3M's R&D investment strategy, detailing the specific areas of research and development the company is focusing on, including application development, product development, and technology development aimed at disruptive innovations.",
"context": "Research, Development and Related Expenses: R&D, measured as a percent of sales, increased in 2023 when compared to 2022. 3M continues to invest in a range of R&D activities from application development, product and manufacturing support, product development and technology development aimed at disruptive innovations. R&D was also impacted by restructuring charges. The Company continues to make investments in the implementation of new business systems and solutions, including enterprise resource planning, with these investments impacting cost of sales, SG&A, and R&D.",
"statement": "3M continues to invest in a range of R&D activities from application development, product and manufacturing support, product development and technology development aimed at disruptive innovations.",
"topic": "R&D"
},
{
"analysis": "This statement describes 3M's investments in laboratory facilities, which are directly related to research and development efforts.",
"context": "Cash Flows from Investing Activities: 3M invests in renewal and maintenance programs, which pertain to cost reduction, cycle time, maintaining and renewing current capacity, eliminating pollution, and compliance. Costs related to maintenance, ordinary repairs, and certain other items are expensed. 3M also invests in growth, which adds to capacity, driven by new products, both through expansion of current facilities and new facilities. Finally, 3M also invests in other initiatives, such as information technology (IT), laboratory facilities, and a continued focus on investments in sustainability.",
"statement": "3M also invests in other initiatives, such as information technology (IT), laboratory facilities, and a continued focus on investments in sustainability.",
"topic": "R&D"
},
{
"analysis": "This statement describes 3M's accounting treatment for software development costs, specifically mentioning the capitalization of internal-use software development costs.",
"context": "Property, plant and equipment, including capitalized interest and internal direct engineering costs, are recorded at cost. The Company capitalizes direct costs of services used in the development of, and external software acquired for use as, internal-use software. These software amounts are reported as a component of machinery and equipment within PPE. Depreciation of PPE generally is computed using the straight-line method. Refer to Note 7 for depreciable life and additional details on PPE. Internal-use software elements of PPE are depreciated over a period of three to seven years.",
"statement": "3M capitalizes direct costs of services used in the development of, and external software acquired for use as, internal-use software.",
"topic": "Software"
},
{
"analysis": "This statement provides specific financial data on 3M's R&D spending over three years, indicating the company's commitment to research and development efforts.",
"context": "Research, development and related expenses totaled $1.8 billion, $1.9 billion and $2.0 billion in 2023, 2022 and 2021, respectively. Research and development expenses, covering basic scientific research and the application of scientific advances in the development of new and improved products and their uses, totaled $1.0 billion, $1.1 billion and $1.2 billion in 2023, 2022 and 2021, respectively. Related expenses primarily include technical support; internally developed patent costs, which include costs and fees incurred to prepare, file, secure and maintain patents; amortization of externally acquired patents and externally acquired in-process research and development; and gains/losses associated with certain corporate approved investments in R&D-related ventures.",
"statement": "Research, development and related expenses totaled $1.8 billion, $1.9 billion and $2.0 billion in 2023, 2022 and 2021, respectively.",
"topic": "R&D"
},
{
"analysis": "This refers to a specific software product offered by 3M's Health Care business segment for healthcare billing and reimbursement processes.",
"context": "Health Care business segment representative products: \"Health care procedure coding and reimbursement software\"",
"statement": "Health care procedure coding and reimbursement software",
"topic": "Software"
},
{
"analysis": "This refers to 3M's products/services related to data center infrastructure, which is part of their Transportation and Electronics business segment offerings.",
"context": "Transportation and Electronics business segment representative products: \"Solutions for data centers\"",
"statement": "Solutions for data centers",
"topic": "Compute Infra"
},
{
"analysis": "This refers to enterprise-level software systems used by 3M, which are considered corporate assets rather than being attributed to specific business segments.",
"context": "Assets subject to attribution to business segments: \"certain items such as corporate-shared headquarters/administrative centers, laboratories, distribution centers and enterprise software systems are reflected in Corporate and Unallocated.\"",
"statement": "enterprise software systems",
"topic": "Software"
}
] |
[
{
"analysis": "This statement directly indicates 3M's potential development and use of AI technology in business operations, as part of their risk assessment.",
"context": "The Company or its third-party vendors may develop or incorporate artificial intelligence technology in certain business processes, services or products. The development and use of artificial intelligence may present risks to the Company's business. Also, the rapidly evolving legal and regulatory environment relating to artificial intelligence, in the United States and internationally, could impact the Company's implementation of artificial intelligence technology, and increase compliance costs and the risk of non-compliance.",
"context_length": null,
"statement": "The Company or its third-party vendors may develop or incorporate artificial intelligence technology in certain business processes, services or products.",
"topic": "AI"
},
{
"analysis": "This statement directly describes 3M's investment in R&D activities focused on disruptive innovations, which falls under the R&D topic.",
"context": "Research, development and related expenses (R&D) decreased in 2024 when compared to 2023 and increased in 2023 when compared to 2022. 3M continues to invest in a range of R&D activities from application development, product and manufacturing support, product development and technology development aimed at disruptive innovations. R&D was also impacted by restructuring charges.",
"context_length": null,
"statement": "3M continues to invest in a range of R&D activities from application development, product and manufacturing support, product development and technology development aimed at disruptive innovations.",
"topic": "R&D"
},
{
"analysis": "This statement directly describes 3M's investment in enterprise resource planning (ERP) systems, which is a form of enterprise software.",
"context": "The Company continues to make investments in the implementation of new business systems and solutions, including enterprise resource planning, with these investments impacting cost of sales, SG&A, and R&D.",
"context_length": null,
"statement": "The Company continues to make investments in the implementation of new business systems and solutions, including enterprise resource planning, with these investments impacting cost of sales, SG&A, and R&D.",
"topic": "Software"
},
{
"analysis": "The statement identifies R&D as one of the key areas the company will prioritize for capital deployment, directly relating to their R&D investment strategy.",
"context": "The strength and stability of 3M's business model and strong free cash flow capability, together with proven capital markets access, provide financial flexibility to deploy capital in accordance with the Company's stated priorities and meet needs associated with contractual commitments and other obligations. Investing in 3M's business to drive organic growth and deliver strong returns on invested capital remains the first priority for capital deployment. This includes research and development, capital expenditures, and commercialization capability.",
"context_length": null,
"statement": "This includes research and development, capital expenditures, and commercialization capability.",
"topic": "R&D"
},
{
"analysis": "This statement provides the company's R&D spending figures for the past three years, directly reporting on their R&D activities.",
"context": "Research, Development and Related Expenses: These costs are charged to operations in the period incurred and are shown on a separate line of the Consolidated Statement of Income. Research, development and related expenses totaled $ 1.1billion, $ 1.2billion and $ 1.2billion in 2024, 2023 and 2022, respectively.",
"context_length": null,
"statement": "Research, development and related expenses totaled $ 1.1billion, $ 1.2billion and $ 1.2billion in 2024, 2023 and 2022, respectively.",
"topic": "R&D"
},
{
"analysis": "This statement describes 3M's accounting policy for capitalizing costs related to internal-use software development and acquisition.",
"context": "Property, Plant and Equipment (PPE) and Definite-Lived Intangible Assets: Property, plant and equipment, including capitalized interest and internal direct engineering costs, are recorded at cost. The Company capitalizes direct costs of services used in the development of, and external software acquired for use as, internal-use software. These software amounts are reported as a component of machinery and equipment within PPE. Depreciation of PPE generally is computed using the straight-line method. Refer to Note 8 for depreciable life and additional details on PPE. Internal-use software elements of PPE are depreciated over a period of three to seven years.",
"context_length": null,
"statement": "3M capitalizes direct costs of services used in the development of, and external software acquired for use as, internal-use software.",
"topic": "Software"
},
{
"analysis": "This statement directly describes 3M's implementation of an enterprise resource planning system, which is a type of proprietary enterprise software designed to improve business processes.",
"context": "The Company continues to implement new business systems and solutions, including an enterprise resource planning system (ERP), which are expected to improve the efficiency of certain financial and related business processes. These implementations are expected to occur on an on-going basis as opportunities and needs are identified and addressed. The implementations, in certain cases, may affect the processes that constitute the Company's internal control over financial reporting and will require testing for effectiveness.",
"context_length": null,
"statement": "The Company continues to implement new business systems and solutions, including an enterprise resource planning system (ERP), which are expected to improve the efficiency of certain financial and related business processes.",
"topic": "Software"
}
] |
[
{
"analysis": "This statement describes 3M's software license contracts and how revenue from these contracts is recognized, directly relating to the company's software business activities.",
"context": "Note 2 (Revenue) states: \"Deferred revenue primarily relates to revenue that is recognized over time for one-year software license contracts. Deferred revenue (current portion) as of March 31, 2022 and December 31, 2021 was $549 million and $529 million, respectively. Approximately $200 million of the December 31, 2021 balance was recognized as revenue during the three months ended March 31, 2022, while approximately $180 million of the December 31, 2020 balance was recognized as revenue during the three months ended March 31, 2021.\"",
"statement": "Deferred revenue primarily relates to revenue that is recognized over time for one-year software license contracts.",
"topic": "Software"
},
{
"analysis": "This statement directly describes 3M's R&D investments in disruptive innovation programs aimed at creating new markets and disrupting existing ones.",
"context": "Research, development and related expenses (R&D) decreased in the first three months of 2022 when compared to the same period last year. 3M continued to invest in its key initiatives, including R&D aimed at disruptive innovation programs with the potential to create entirely new markets and disrupt existing markets.",
"statement": "3M continued to invest in its key initiatives, including R&D aimed at disruptive innovation programs with the potential to create entirely new markets and disrupt existing markets.",
"topic": "R&D"
},
{
"analysis": "This statement describes 3M's deployment of an enterprise resource planning (ERP) system, which is a type of enterprise software used across the organization.",
"context": "The Company is continuing the ongoing deployment of an enterprise resource planning (ERP) system on a worldwide basis, with these investments impacting cost of sales, SG&A, and R&D.",
"statement": "The Company is continuing the ongoing deployment of an enterprise resource planning (ERP) system on a worldwide basis, with these investments impacting cost of sales, SG&A, and R&D.",
"topic": "Software"
},
{
"analysis": "This statement describes 3M's global implementation of an enterprise resource planning system, which is a type of enterprise software designed to improve business efficiency and transaction processes.",
"context": "This statement appears in the 'CAUTIONARY NOTE CONCERNING FACTORS THAT MAY AFFECT FUTURE RESULTS' section, where it's listed as a forward-looking statement related to the Company's expected future business and financial performance. The statement is part of the discussion of forward-looking statements about the Company's strategy for growth and future business performance.",
"statement": "The Company is implementing an enterprise resource planning (\"ERP\") system on a worldwide basis, which is expected to improve the efficiency of certain financial and related transaction processes. The gradual implementation is expected to occur in phases over the next several years.",
"topic": "Software"
},
{
"analysis": "This statement describes 3M's use of enterprise resource planning software as part of its business transformation strategy to improve operational efficiency across its global operations.",
"context": "This statement appears in the 'Risks Related to Our Business' section under the risk factor 'The Company employs information technology systems to support its business, including ongoing phased implementation of an enterprise resource planning (ERP) system as part of business transformation on a worldwide basis over the next several years.' It's listed as a risk related to the Company's information technology infrastructure and systems.",
"statement": "The Company employs information technology systems to support its business, including ongoing phased implementation of an enterprise resource planning (ERP) system as part of business transformation on a worldwide basis over the next several years.",
"topic": "Software"
}
] |
[
{
"analysis": "Describes 3M's R&D investment activities, including specific areas of focus (application development, product development, technology development) and their goal (disruptive innovations).",
"context": "From the 'Research, Development and Related Expenses' section: 'R&D, measured as a percent of sales, decreased in the first three and six months of 2022 when compared to the same period last year. 3M continues to invest in a range of R&D activities from application development, product and manufacturing support, product development and technology development aimed at disruptive innovations.' This section discusses R&D expenses and their impact on the company's financials.",
"statement": "R&D, measured as a percent of sales, decreased in the first three and six months of 2022 when compared to the same period last year. 3M continues to invest in a range of R&D activities from application development, product and manufacturing support, product development and technology development aimed at disruptive innovations.",
"topic": "R&D"
},
{
"analysis": "Describes 3M's deployment of an enterprise resource planning (ERP) system, a type of enterprise software, as part of their software infrastructure.",
"context": "From the 'The Company is continuing the ongoing deployment of an enterprise resource planning (ERP) system on a worldwide basis, with these investments impacting cost of sales, SG&A, and R&D.' section. This appears in the document discussing the company's investments in various business functions, noting that the ERP deployment impacts cost of sales, SG&A, and R&D.",
"statement": "The Company is continuing the ongoing deployment of an enterprise resource planning (ERP) system on a worldwide basis, with these investments impacting cost of sales, SG&A, and R&D.",
"topic": "Software"
},
{
"analysis": "This statement identifies R&D as a key priority for capital deployment to drive organic growth and deliver strong returns on invested capital.",
"context": "The strength and stability of 3M's business model and strong free cash flow capability, together with proven capital markets access, provide financial flexibility to deploy capital in accordance with the Company's stated priorities and meet needs associated with contractual commitments and other obligations. Investing in 3M's business to drive organic growth and deliver strong returns on invested capital remains the first priority for capital deployment. This includes research and development, capital expenditures, and commercialization capability.",
"statement": "Investing in 3M's business to drive organic growth and deliver strong returns on invested capital remains the first priority for capital deployment. This includes research and development, capital expenditures, and commercialization capability.",
"topic": "R&D"
}
] |
[
{
"analysis": "This statement directly refers to software license contracts, which falls under the 'Software' topic as it discusses the nature of software-related revenue recognition.",
"context": "Note 2 (Revenue) under 'Contract Balances' section: 'Deferred revenue primarily relates to revenue that is recognized over time for one-year software license contracts. Deferred revenue (current portion) as of September 30, 2022 and December 31, 2021 was $506 million and $529 million, respectively.'",
"statement": "Deferred revenue primarily relates to revenue that is recognized over time for one-year software license contracts.",
"topic": "Software"
},
{
"analysis": "This statement refers to environmental compliance work with agencies, not research and development efforts as defined in the topic list.",
"context": "The Company continues to work with relevant federal and state agencies (including EPA, the U.S. Department of Justice, state environmental agencies and state attorneys general) as it conducts these reviews and responds to information, inspection, and other requests from the agencies.",
"statement": "The Company continues to work with relevant federal and state agencies",
"topic": "R&D"
},
{
"analysis": "This statement describes 3M's deployment of an enterprise resource planning (ERP) system, which is a type of enterprise software.",
"context": "3M expects to contribute approximately $100 million to $200 million of cash to its global defined benefit pension and postretirement plans in 2022. The Company does not have a required minimum cash pension contribution obligation for its U.S. plans in 2022. 3M expects global defined benefit pension and postretirement service cost expense in 2022 to decrease by approximately $68 million pre-tax when compared to 2021, which impacts cost of sales; selling, general and administrative expenses (SG&A); and research, development and related expenses (R&D). The Company is continuing the ongoing deployment of an enterprise resource planning (ERP) system on a worldwide basis, with these investments impacting cost of sales, SG&A, and R&D.",
"statement": "The Company is continuing the ongoing deployment of an enterprise resource planning (ERP) system on a worldwide basis, with these investments impacting cost of sales, SG&A, and R&D.",
"topic": "Software"
},
{
"analysis": "Directly mentions research and development as a priority for capital deployment.",
"context": "Investing in 3M's business to drive organic growth and deliver strong returns on invested capital remains the first priority for capital deployment. This includes research and development, capital expenditures, and commercialization capability. The Company also continues to actively manage its portfolio through acquisitions and divestitures to maximize value for shareholders.",
"statement": "This includes research and development, capital expenditures, and commercialization capability.",
"topic": "R&D"
},
{
"analysis": "Specifically describes the implementation of an enterprise resource planning (ERP) system, which is a type of enterprise software.",
"context": "The Company is implementing an enterprise resource planning (\"ERP\") system on a worldwide basis, which is expected to improve the efficiency of certain financial and related transaction processes. The gradual implementation is expected to occur in phases over the next several years. The implementation of a worldwide ERP system will likely affect the processes that constitute the Company's internal control over financial reporting and will require testing for effectiveness.",
"statement": "The Company is implementing an enterprise resource planning (\"ERP\") system on a worldwide basis, which is expected to improve the efficiency of certain financial and related transaction processes.",
"topic": "Software"
},
{
"analysis": "This describes 3M's implementation of an ERP system, which is enterprise software, as part of their business transformation strategy.",
"context": "The Company employs information technology systems to support its business and collect, store and use proprietary and confidential information, including ongoing phased implementation of an enterprise resource planning (ERP) system as part of business transformation on a worldwide basis over the next several years.",
"statement": "ongoing phased implementation of an enterprise resource planning (ERP) system as part of business transformation on a worldwide basis over the next several years.",
"topic": "Software"
}
] |
[
{
"analysis": "This statement directly reports on 3M's R&D spending as a percentage of sales, noting an increase compared to the previous year, indicating continued investment in research and development activities.",
"context": "Research, Development and Related Expenses:\n\nR&D, measured as a percent of sales, increased in the first three months of 2023 when compared to the same period last year. 3M continues to invest in a range of R&D activities from application development, product and manufacturing support, product development and technology development aimed at disruptive innovations.\nThe Company is continuing the ongoing deployment of an enterprise resource planning (ERP) system on a worldwide basis, with these investments impacting cost of sales, SG&A, and R&D.",
"statement": "R&D, measured as a percent of sales, increased in the first three months of 2023 when compared to the same period last year.",
"topic": "R&D"
},
{
"analysis": "The company states that R&D expenses as a percentage of sales increased in Q1 2023 compared to Q1 2022, indicating continued investment in research and development activities.",
"context": "Research, Development and Related Expenses:\nR&D, measured as a percent of sales, increased in the first three months of 2023 when compared to the same period last year. 3M continues to invest in a range of R&D activities from application development, product and manufacturing support, product development and technology development aimed at disruptive innovations.",
"statement": "R&D, measured as a percent of sales, increased in the first three months of 2023 when compared to the same period last year.",
"topic": "R&D"
},
{
"analysis": "This statement identifies artificial intelligence as one of the disruptive technologies affecting the company's business environment, indicating awareness of AI's industry impact.",
"context": "Risks Related to Our Products and Customer Preferences: 'Demand for the Company’s products, which impacts revenue and profit margins, is affected by, among other things, (i) the development and timing of the introduction of competitive products; (ii) the Company’s pricing strategies; (iii) changes in customer order patterns, such as changes in the levels of inventory maintained by customers, vendors, or channel partners; (iv) changes in customers’ preferences for our products, including the success of products offered by our competitors, and changes in customer designs for their products that can affect the demand for some of the Company’s products; and (v) changes in the business environment related to disruptive technologies, such as artificial intelligence, block-chain, expanded analytics, and other enhanced learnings from increasing volume of available data.'",
"statement": "changes in the business environment related to disruptive technologies, such as artificial intelligence, block-chain, expanded analytics, and other enhanced learnings from increasing volume of available data.",
"topic": "AI"
},
{
"analysis": "This statement describes 3M's specific initiative to implement an enterprise resource planning (ERP) system globally, which is a major enterprise software implementation.",
"context": "Risks Related to Our Business: 'The Company employs information technology systems to support its business and collect, store, and use proprietary and confidential information, including ongoing phased implementation of an enterprise resource planning (ERP) system as part of business transformation on a worldwide basis over the next several years. The Company is implementing an enterprise resource planning (“ERP”) system on a worldwide basis, which is expected to improve the efficiency of certain financial and related transaction processes. The gradual implementation is expected to occur in phases over the next several years.'",
"statement": "The Company is implementing an enterprise resource planning (“ERP”) system on a worldwide basis, which is expected to improve the efficiency of certain financial and related transaction processes.",
"topic": "Software"
}
] |
[
{
"analysis": "This statement directly indicates 3M has software license contracts as part of their business, showing proprietary software products generating revenue through licensing.",
"context": "Deferred revenue primarily relates to revenue that is recognized over time for one-year software license contracts. Deferred revenue (current portion) as of June 30, 2023 and December 31, 2022 was $521 million and $538 million, respectively. Approximately $150 million and $350 million of the December 31, 2022 balance was recognized as revenue during the three and six months ended June 30, 2023, respectively, while approximately $140 million and $340 million of the December 31, 2021 balance was recognized as revenue during the three and six months ended June 30, 2022, respectively.",
"statement": "Deferred revenue primarily relates to revenue that is recognized over time for one-year software license contracts.",
"topic": "Software"
},
{
"analysis": "Directly references proprietary software license contracts and revenue recognition, indicating the company's software business activities.",
"context": "Deferred revenue primarily relates to revenue that is recognized over time for one-year software license contracts. Deferred revenue (current portion) as of June 30, 2023 and December 31, 2022 was $521 million and $538 million, respectively. Approximately $150 million and $350 million of the December 31, 2022 balance was recognized as revenue during the three and six months ended June 30, 2023, respectively.",
"statement": "Deferred revenue primarily relates to revenue that is recognized over time for one-year software license contracts.",
"topic": "Software"
},
{
"analysis": "Direct statement about 3M's R&D investment as a percentage of sales, indicating increased R&D spending.",
"context": "R&D, measured as a percent of sales, increased in the second quarter and first six months of 2023 when compared to the same period last year. 3M continues to invest in a range of R&D activities from application development, product and manufacturing support, product development and technology development aimed at disruptive innovations. R&D was also impacted by restructuring charges.",
"statement": "R&D, measured as a percent of sales, increased in the second quarter and first six months of 2023 when compared to the same period last year.",
"topic": "R&D"
},
{
"analysis": "Statement about 3M's deployment of an enterprise resource planning (ERP) software system, which is a type of enterprise software.",
"context": "The Company is continuing the ongoing deployment of an enterprise resource planning (ERP) system on a worldwide basis, with these investments impacting cost of sales, SG&A, and R&D.",
"statement": "The Company is continuing the ongoing deployment of an enterprise resource planning (ERP) system on a worldwide basis, with these investments impacting cost of sales, SG&A, and R&D.",
"topic": "Software"
},
{
"analysis": "Identifies R&D as a priority area for capital deployment, indicating it's a focus for the company's investment strategy.",
"context": "Investing in 3M's business to drive organic growth and deliver strong returns on invested capital remains the first priority for capital deployment. This includes research and development, capital expenditures, and commercialization capability. The Company also continues to actively manage its portfolio through acquisitions and divestitures to maximize value for shareholders.",
"statement": "This includes research and development, capital expenditures, and commercialization capability.",
"topic": "R&D"
},
{
"analysis": "Describes the implementation of an ERP system, a type of enterprise software, to improve financial and transactional processes.",
"context": "The Company is implementing an enterprise resource planning (\"ERP\") system on a worldwide basis, which is expected to improve the efficiency of certain financial and related transaction processes. The gradual implementation is expected to occur in phases over the next several years. The implementation of a worldwide ERP system will likely affect the processes that constitute the Company's internal control over financial reporting and will require testing for effectiveness.",
"statement": "The Company is implementing an enterprise resource planning (\"ERP\") system on a worldwide basis, which is expected to improve the efficiency of certain financial and related transaction processes.",
"topic": "Software"
}
] |
[
{
"analysis": "This statement directly references software license contracts, which falls under the company's proprietary software business and revenue recognition practices.",
"context": "Deferred revenue primarily relates to revenue that is recognized over time for one-year software license contracts. Deferred revenue (current portion) as of September 30, 2023 and December 31, 2022 was $501 million and $538 million, respectively. Approximately $110 million and $460 million of the December 31, 2022 balance was recognized as revenue during the three and nine months ended September 30, 2023, respectively, while approximately $100 million and $440 million of the December 31, 2021 balance was recognized as revenue during the three and nine months ended September 30, 2022, respectively.",
"statement": "Deferred revenue primarily relates to revenue that is recognized over time for one-year software license contracts.",
"topic": "Software"
},
{
"analysis": "The statement explicitly describes the company's software license revenue recognition model, directly relating to proprietary software business activities.",
"context": "Deferred revenue primarily relates to revenue that is recognized over time for one-year software license contracts. Deferred revenue (current portion) as of September 30, 2023 and December 31, 2022 was $501 million and $538 million, respectively. Approximately $110 million and $460 million of the December 31, 2022 balance was recognized as revenue during the three and nine months ended September 30, 2023, respectively.",
"statement": "Deferred revenue primarily relates to revenue that is recognized over time for one-year software license contracts.",
"topic": "Software"
},
{
"analysis": "This statement describes 3M's ongoing R&D investments across multiple development areas focused on innovative solutions.",
"context": "R&D, measured as a percent of sales, decreased in the third quarter and increased the first nine months of 2023 when compared to the same period last year. 3M continues to invest in a range of R&D activities from application development, product and manufacturing support, product development and technology development aimed at disruptive innovations. R&D was also impacted by restructuring charges.",
"statement": "3M continues to invest in a range of R&D activities from application development, product and manufacturing support, product development and technology development aimed at disruptive innovations.",
"topic": "R&D"
},
{
"analysis": "This statement describes 3M's investments in software systems, specifically mentioning enterprise resource planning as part of their business solutions.",
"context": "The Company continues to make investments in the implementation of new business systems and solutions, including enterprise resource planning, with these investments impacting cost of sales, SG&A, and R&D.",
"statement": "The Company continues to make investments in the implementation of new business systems and solutions, including enterprise resource planning, with these investments impacting cost of sales, SG&A, and R&D.",
"topic": "Software"
},
{
"analysis": "This statement describes 3M's implementation of an enterprise resource planning system as part of its business transformation, which is a software implementation effort.",
"context": "The Company employs information including operational technology systems to support its business and to collect, store, and/or use proprietary and confidential information, including ongoing phased implementation of an enterprise resource planning (ERP) system as part of its business transformation on a worldwide basis over the next several years. Security and data breaches, cyberattacks, and other cybersecurity incidents involving the Company's information technology systems, networks and infrastructure could disrupt or interfere with the Company's operations; result in the compromise and misappropriation of proprietary and confidential information belonging to the Company or its customers, suppliers, and employees; and expose the Company to numerous expenses, liabilities, and other negative consequences, any or all of which could adversely impact the Company's business, reputation, and results of operations.",
"statement": "including ongoing phased implementation of an enterprise resource planning (ERP) system as part of its business transformation on a worldwide basis over the next several years.",
"topic": "Software"
},
{
"analysis": "The company is implementing an ERP system, a form of enterprise software, as part of its global business transformation initiative.",
"context": "The Company employs information including operational technology systems to support its business and to collect, store, and/or use proprietary and confidential information, including ongoing phased implementation of an enterprise resource planning (ERP) system as part of its business transformation on a worldwide basis over the next several years. Security and data breaches, cyberattacks, and other cybersecurity incidents involving the Company’s information technology systems, networks and infrastructure could disrupt or interfere with the Company’s operations; result in the compromise and misappropriation of proprietary and confidential information belonging to the Company or its customers, suppliers, and employees; and expose the Company to numerous expenses, liabilities, and other negative consequences, any or all of which could adversely impact the Company’s business, reputation, and results of operations.",
"statement": "ongoing phased implementation of an enterprise resource planning (ERP) system as part of its business transformation on a worldwide basis over the next several years.",
"topic": "Software"
}
] |
[
{
"analysis": "The statement directly identifies R&D as a priority for capital deployment, indicating the company's focus on research and development efforts.",
"context": "The strength and stability of 3M's business model and strong free cash flow capability, together with proven capital markets access, provide financial flexibility to deploy capital in accordance with the Company's stated priorities and meet needs associated with contractual commitments and other obligations. Investing in 3M's business to drive organic growth and deliver strong returns on invested capital remains the first priority for capital deployment. This includes research and development, capital expenditures, and commercialization capability.",
"statement": "Investing in 3M's business to drive organic growth and deliver strong returns on invested capital remains the first priority for capital deployment. This includes research and development, capital expenditures, and commercialization capability.",
"topic": "R&D"
},
{
"analysis": "The statement discusses the implementation of an enterprise resource planning system (ERP), which is a type of enterprise software, indicating the company's use of enterprise software solutions.",
"context": "The Company continues to implement new business systems and solutions, including an enterprise resource planning system (ERP), which are expected to improve the efficiency of certain financial and related business processes. These implementations are expected to occur on an on-going basis as opportunities and needs are identified and addressed. The implementations, in certain cases, may affect the processes that constitute the Company's internal control over financial reporting and will require testing for effectiveness.",
"statement": "The Company continues to implement new business systems and solutions, including an enterprise resource planning system (ERP), which are expected to improve the efficiency of certain financial and related business processes.",
"topic": "Software"
},
{
"analysis": "This statement mentions AI as a disruptive technology in the market environment, but does not discuss 3M's specific AI activities, development, or adoption. It's a general market trend reference, not a statement about 3M's own AI initiatives.",
"context": "Risks Related to Our Products and Customer Preferences\n* The Company’s results are affected by competitive conditions and customer preferences.\nDemand for the Company’s products, which impacts revenue and profit margins, is affected by, among other things, (i) the development and timing of the introduction of competitive products; (ii) the Company’s pricing strategies; (iii) changes in customer order patterns, such as changes in the levels of inventory maintained by customers, vendors, or channel partners; (iv) changes in customers’ preferences for our products, including the success of products offered by our competitors, and changes in customer designs for their products that can affect the demand for some of the Company’s products; and (v) changes in the business environment related to disruptive technologies, such as artificial intelligence and machine learning technologies, block-chain, expanded analytics, and other enhanced learnings from increasing volume of available data.",
"statement": "changes in the business environment related to disruptive technologies, such as artificial intelligence and machine learning technologies, block-chain, expanded analytics, and other enhanced learnings from increasing volume of available data.",
"topic": "AI"
}
] |
[
{
"analysis": "This statement directly describes 3M's ongoing R&D investment activities, specifically mentioning the areas of focus and the goal of developing disruptive innovations.",
"context": "Research, Development and Related Expenses: R&D, measured as a percent of sales, slightly decreased in the second quarter and first six months of 2024 when compared to the same period last year. 3M continues to invest in a range of R&D activities from application development, product and manufacturing support, product development and technology development aimed at disruptive innovations.",
"statement": "3M continues to invest in a range of R&D activities from application development, product and manufacturing support, product development and technology development aimed at disruptive innovations.",
"topic": "R&D"
},
{
"analysis": "Identifies R&D as a priority for capital deployment, directly relating to the company's R&D efforts.",
"context": "Investing in 3M's business to drive organic growth and deliver strong returns on invested capital remains the first priority for capital deployment. This includes research and development, capital expenditures, and commercialization capability.",
"statement": "This includes research and development, capital expenditures, and commercialization capability.",
"topic": "R&D"
},
{
"analysis": "Discusses potential disruptions to the company's information technology infrastructure, which falls under Compute Infrastructure.",
"context": "unanticipated problems or delays with the phased implementation of a global enterprise resource planning (ERP) system, or security breaches and other disruptions to the Company's information technology infrastructure, or security breaches and other disruptions to the Company's information technology infrastructure,",
"statement": "unanticipated problems or delays with the phased implementation of a global enterprise resource planning (ERP) system, or security breaches and other disruptions to the Company's information technology infrastructure",
"topic": "Compute Infra"
},
{
"analysis": "Describes the company's ongoing implementation of new business systems (ERP), which is related to computing and data infrastructure.",
"context": "The Company continues to implement new business systems and solutions, including an enterprise resource planning system (ERP), which are expected to improve the efficiency of certain financial and related business processes. These implementations are expected to occur on an on-going basis as opportunities and needs are identified and addressed.",
"statement": "The Company continues to implement new business systems and solutions, including an enterprise resource planning system (ERP), which are expected to improve the efficiency of certain financial and related business processes.",
"topic": "Compute Infra"
},
{
"analysis": "The company identifies AI as one of several disruptive technologies that could impact customer preferences and demand for its products.",
"context": "Demand for the Company's products, which impacts revenue and profit margins, is affected by, among other things, (i) the development and timing of the introduction of competitive products; (ii) the Company's pricing strategies; (iii) changes in customer order patterns, such as changes in the levels of inventory maintained by customers, vendors, or channel partners; (iv) changes in customers' preferences for our products, including preferences for products that do not contain PFAS, the success of products offered by our competitors, and changes in customer designs for their products that can affect the demand for some of the Company's products; and (v) changes in the business environment related to disruptive technologies, such as artificial intelligence and machine learning technologies, block-chain, expanded analytics, and other enhanced learnings from increasing volume of available data.",
"statement": "changes in the business environment related to disruptive technologies, such as artificial intelligence and machine learning technologies, block-chain, expanded analytics, and other enhanced learnings from increasing volume of available data.",
"topic": "AI"
},
{
"analysis": "The company describes its implementation of an ERP system as part of its business transformation efforts.",
"context": "The Company employs information including operational technology systems to support its business and to collect, store, and/or use proprietary and confidential information, including ongoing phased implementation of an enterprise resource planning (ERP) system as part of its business transformation on a worldwide basis over the next several years. Security and data breaches, cyberattacks, and other cybersecurity incidents involving the Company's information technology systems, networks and infrastructure could disrupt or interfere with the Company's operations; result in the compromise and misappropriation of proprietary and confidential information belonging to the Company or its customers, suppliers, and employees; and expose the Company to numerous expenses, liabilities, and other negative consequences, any or all of which could adversely impact the Company's business, reputation, and results of operations.",
"statement": "ongoing phased implementation of an enterprise resource planning (ERP) system as part of its business transformation on a worldwide basis over the next several years.",
"topic": "Software"
}
] |
[
{
"analysis": "This statement directly describes 3M's ongoing R&D investment activities and their focus areas, specifically mentioning application development and technology development.",
"context": "Research, Development and Related Expenses: R&D, measured as a percent of sales, was consistent in the third quarter and decreased in the first nine months of 2024 when compared to the same period last year. 3M continues to invest in a range of R&D activities from application development, product and manufacturing support, product development and technology development aimed at disruptive innovations. See also Certain Expenses Impacting Multiple Line Items within Results of Operations subsection further below.",
"statement": "3M continues to invest in a range of R&D activities from application development, product and manufacturing support, product development and technology development aimed at disruptive innovations.",
"topic": "R&D"
},
{
"analysis": "This statement explicitly identifies R&D as a priority investment area for the company, indicating its commitment to research and development efforts.",
"context": "Investing in 3M's business to drive organic growth and deliver strong returns on invested capital remains the first priority for capital deployment. This includes research and development, capital expenditures, and commercialization capability. The Company also continues to actively manage its portfolio through acquisitions and divestitures to maximize value for shareholders.",
"statement": "Investing in 3M's business to drive organic growth and deliver strong returns on invested capital remains the first priority for capital deployment. This includes research and development, capital expenditures, and commercialization capability.",
"topic": "R&D"
},
{
"analysis": "This statement discusses potential challenges with ERP system implementation and related infrastructure, indicating the company's focus on technology infrastructure management.",
"context": "unanticipated problems or delays with the phased implementation of a global enterprise resource planning (ERP) system, or security breaches and other disruptions to the Company's information or operational technology infrastructure,",
"statement": "unanticipated problems or delays with the phased implementation of a global enterprise resource planning (ERP) system, or security breaches and other disruptions to the Company's information or operational technology infrastructure,",
"topic": "Compute Infra"
},
{
"analysis": "This statement directly addresses 3M's potential development and incorporation of AI technology into its business processes, services, and products, indicating future plans for AI adoption.",
"context": "The Company or its third-party vendors may develop or incorporate artificial intelligence technology in certain business processes, services or products. The development and use of artificial intelligence may present risks to the Company's business. Also, the rapidly evolving legal and regulatory environment relating to artificial intelligence, in the United States and internationally, could impact the Company's implementation of artificial intelligence technology, and increase compliance costs and the risk of non-compliance. While the Company will seek to develop and use artificial intelligence responsibly, and will attempt to identify and mitigate ethical, privacy, legal or other issues presented by its use, there can be no assurance that the Company will be fully successful in doing so, and may be subject to data breaches, allegations of unauthorized access to, or use of, third party data, information, or intellectual property rights, or other risks, which may lead to financial losses, legal liability, regulatory scrutiny and reputational damage.",
"statement": "The Company or its third-party vendors may develop or incorporate artificial intelligence technology in certain business processes, services or products.",
"topic": "AI"
}
] |
[
{
"analysis": "This statement explicitly discusses 3M's ongoing investment in R&D activities across multiple development areas with the goal of achieving disruptive innovations.",
"context": "R&D measured as a percent of sales: 3M continues to invest in a range of R&D activities from application development, product and manufacturing support, product development and technology development aimed at disruptive innovations. See also Certain Expenses Impacting Multiple Line Items within Results of Operations subsection further below.",
"statement": "3M continues to invest in a range of R&D activities from application development, product and manufacturing support, product development and technology development aimed at disruptive innovations.",
"topic": "R&D"
},
{
"analysis": "This statement explicitly identifies R&D as a key area for capital deployment to drive organic growth and deliver strong returns on invested capital.",
"context": "The strength and stability of 3M's business model and strong free cash flow capability, together with proven capital markets access, provide financial flexibility to deploy capital in accordance with the Company's stated priorities and meet needs associated with contractual commitments and other obligations. Investing in 3M's business to drive organic growth and deliver strong returns on invested capital remains the first priority for capital deployment. This includes research and development, capital expenditures, and commercialization capability. The Company also continues to actively manage its portfolio through acquisitions and divestitures to maximize value for shareholders.",
"statement": "Investing in 3M's business to drive organic growth and deliver strong returns on invested capital remains the first priority for capital deployment. This includes research and development, capital expenditures, and commercialization capability.",
"topic": "R&D"
},
{
"analysis": "This statement directly addresses 3M's potential development and incorporation of AI technology in business processes, services, or products, making it relevant to the AI topic.",
"context": "The Company or its third-party vendors may develop or incorporate artificial intelligence technology in certain business processes, services or products. The development and use of artificial intelligence may present risks to the Company's business. Also, the rapidly evolving legal and regulatory environment relating to artificial intelligence, in the United States and internationally, could impact the Company's implementation of artificial intelligence technology, and increase compliance costs and the risk of non-compliance. While the Company will seek to develop and use artificial intelligence responsibly, and will attempt to identify and mitigate ethical, privacy, legal or other issues presented by its use, there can be no assurance that the Company will be fully successful in doing so, and may be subject to data breaches, allegations of unauthorized access to, or use of, third party data, information, or intellectual property rights, or other risks, which may lead to financial losses, legal liability, regulatory scrutiny and reputational damage.",
"statement": "The Company or its third-party vendors may develop or incorporate artificial intelligence technology in certain business processes, services or products.",
"topic": "AI"
},
{
"analysis": "Describes 3M's active deployment of an enterprise software system (ERP) as part of its global business transformation initiative.",
"context": "The Company employs information including operational technology systems to support its business and to collect, store, and/or use proprietary and confidential information, including ongoing phased implementation of an enterprise resource planning (ERP) system as part of its business transformation on a worldwide basis over the next several years. Network disruptions, security and data breaches, cyberattacks, and other cybersecurity incidents involving the Company’s information technology systems, networks and infrastructure could disrupt or interfere with the Company’s operations; result in the compromise and misappropriation of proprietary and confidential information belonging to the Company or its customers, suppliers, and employees; and expose the Company to numerous expenses, liabilities, and other negative consequences, any or all of which could have a material adverse effect on the Company’s business, reputation, and results of operations.",
"statement": "ongoing phased implementation of an enterprise resource planning (ERP) system as part of its business transformation on a worldwide basis over the next several years.",
"topic": "Software"
}
] |
[
{
"analysis": "3M acquired LeanTec's technology assets specifically for digital solutions in the automotive aftermarket segment, indicating investment in software platforms for business applications.",
"context": "Mike Roman stated that the Safety and Industrial business group acquired the technology assets of LeanTec to advance digital solutions for auto body shops. This acquisition is part of 3M's strategy to build for the future through digital platforms that integrate data capture and analysis with material science, providing enhanced productivity and inventory management for customers.",
"statement": "3M acquired the technology assets of LeanTec to advance digital solutions for auto body shops.",
"topic": "Software"
},
{
"analysis": "The statement describes a specific digital platform developed by 3M that integrates data analytics with material science, indicating software development for improved business operations.",
"context": "Mike Roman described the connected bodyshop platform as a digital solution that integrates data capture and analysis with material product platforms. This platform provides shop owners and managers with enhanced data access for improved productivity and inventory management in the automotive aftermarket segment.",
"statement": "This digital platform integrates data capture and analysis with material product platforms.",
"topic": "Software"
}
] |
[
{
"analysis": "This statement describes 3M's plan to strategically leverage its research and development efforts across the entire enterprise to drive business growth.",
"context": "As we look ahead, innovation, talent and operations will remain core strengths for new 3M. We will drive more customer-focused innovation leverage data and insights from our retail partners and connect with customers through advanced e-commerce strategies. We will share technology platforms and leverage R&D across the enterprise, which will help drive growth in all of our businesses.",
"statement": "We will share technology platforms and leverage R&D across the enterprise, which will help drive growth in all of our businesses.",
"topic": "R&D"
},
{
"analysis": "This statement indicates 3M's view that healthcare information systems (a software product) are becoming increasingly important for healthcare providers to deliver better care through data and insights.",
"context": "Our wound care business is a world leader and comprises a portfolio of innovative products. Our oral care business is another leading platform, which has developed award-winning innovations. Health care information systems are increasingly essential, as providers seek to deliver better care through comprehensive data and insights. Our biopharma filtration products are critical to manufacturing potentially life-saving medical devices, vaccines, drugs and therapeutics.",
"statement": "Health care information systems are increasingly essential, as providers seek to deliver better care through comprehensive data and insights.",
"topic": "Software"
},
{
"analysis": "This statement reports the growth performance of 3M's Health Information Systems software business, specifically attributing the growth to strong performance in revenue cycle management.",
"context": "Looking at our Healthcare business, which delivered strong quarter sales of $2.2 billion, with organic growth of 4.4%. Our medical solutions and oral care businesses increased low single digits organically. Second quarter US elective medical procedures and oral care volumes were approximately 90% to 95% of pre-COVID levels, up sequentially from Q1 levels. Health Information Systems grew mid-single digits, driven by strong growth in revenue cycle management. The separation and purification business increased high single digits with sustained demand for biopharma filtration solutions for COVID-related vaccines.",
"statement": "Health Information Systems grew mid-single digits, driven by strong growth in revenue cycle management.",
"topic": "Software"
}
] |
[
{
"analysis": "The company introduced a new app for Microsoft Teams, which is an enterprise software product for collaboration in hybrid environments.",
"context": "We are also innovating to make our operation safer, more efficient and more productive. At our plant in Alexandria, Minnesota, we are leveraging 3M disruptive technologies to transform our abrasive belt converting process through end-to-end automation, improving labor productivity by 32%, eliminating nine high-risk tasks and saving nearly $1 million annually. Many more similar projects are on the way across our global operations, driving safety and savings. In sustainability, we have installed a new state-of-the-art water filtration system in Cordova, Illinois. We now have all three of our largest water using sites in the U.S., utilizing industry-leading filtration technologies following through on the $1 billion sustainability commitment we made last year. At the same time, we are positioning 3M for long-term success by actively managing our portfolio, complementing all we do to strengthen our enterprise organically.",
"statement": "earlier this month, we introduced a new posted app for Microsoft Teams that helps people collaborate in hybrid environments, as we execute our digital strategy and re-imagine our products.",
"topic": "Software"
},
{
"analysis": "The company is using data analytics as part of their computing infrastructure to improve productivity in manufacturing plants.",
"context": "We continue to invest in growth, productivity and sustainability. For example, while we see near-term softness in consumer electronics, we are investing in Electronic segments that are seeing strong growth, including new solutions for automotive displays, and virtual and augmented reality. We are rolling out new thermal management solutions to improve electric car batteries, one element of our work to advance more sustainable vehicle designs. And earlier this month, we introduced a new posted app for Microsoft Teams that helps people collaborate in hybrid environments, as we execute our digital strategy and re-imagine our products. We are also innovating to make our operation safer, more efficient and more productive. At our plant in Alexandria, Minnesota, we are leveraging 3M disruptive technologies to transform our abrasive belt converting process through end-to-end automation, improving labor productivity by 32%, eliminating nine high-risk tasks and saving nearly $1 million annually.",
"statement": "We are leveraging data and data analytics to drive productivity in our plants.",
"topic": "Compute Infra"
},
{
"analysis": "The company is using data analytics to optimize inventory management and customer payment terms, which is part of their computing infrastructure.",
"context": "Third quarter adjusted free cash flow was $1.4 billion, with conversion of 88%, an improvement from first half performance as we drive working capital intensity, including improved inventory levels, while also increasing CapEx for growth and sustainability investments. We remain focused on working capital improvement as we continue to navigate through a fluid supply chain environment. Even though the environment remains challenging, we are realizing benefits from our efforts as we leverage the use of data and data analytics to reduce inventory levels through better demand planning and optimized customer payment terms. We expect to continue to realize benefits from our actions as we move forward.",
"statement": "We are realizing benefits from our efforts as we leverage the use of data and data analytics to reduce inventory levels through better demand planning and optimized customer payment terms.",
"topic": "Compute Infra"
},
{
"analysis": "The company acquired LeanTec to develop proprietary software for auto body shops focused on parts management, expanding their enterprise software offerings in the Safety and Industrial segment.",
"context": "In Safety and Industrial business, we bought the assets of a company called LeanTec that allows us to do software for auto body shops, so parts management through software for auto body shops. So that's starting to take hold and Mike Wale and his team have done a nice job there. And Mike Roman mentioned in his opening remarks, the collaboration we have with Microsoft, where we announced the digital posted note in collaboration with Microsoft.",
"statement": "In Safety and Industrial business, we bought the assets of a company called LeanTec that allows us to do software for auto body shops, so parts management through software for auto body shops.",
"topic": "Software"
},
{
"analysis": "The company explicitly states plans to leverage automation (a key component of AI) within digital operations to improve factory yield and efficiency, particularly as supply chains stabilize.",
"context": "digital operation is the place where you are talking about is from a factory perspective. The team has done a lot of work using data and data analytics to improve yield and efficiency in the factories. For example, we were able to create a digital twin for our respirator production during the pandemic, which the team is continuing to use and those models are being used for other parts of our production lines. There’s a lot more we can do in this area in automation and digitization to drive yield and efficiency and especially as supply chains start normalizing.",
"statement": "There’s a lot more we can do in this area in automation and digitization to drive yield and efficiency and especially as supply chains start normalizing.",
"topic": "AI"
}
] |
[] |
[
{
"analysis": "The company explicitly states they are modernizing their technology infrastructure by moving to the cloud, which is a direct statement about compute infrastructure improvements to reduce costs and increase flexibility.",
"context": "Mike Roman's remarks about the company's actions to improve performance, specifically mentioning simplifying and modernizing technology as part of their cost reduction and efficiency efforts. He states this as part of the company's plan to 'simplify and modernize our technology by moving to the cloud and removing hundreds of legacy systems' to provide 'greater agility and flexibility to invest in differentiated digital areas.'",
"statement": "We are simplifying and modernizing our technology by moving to the cloud and removing hundreds of legacy systems. This reduces costs and provides us greater agility and flexibility to invest in differentiated digital areas like data, analytics and automation while increasing investments in cybersecurity.",
"topic": "Compute Infra"
},
{
"analysis": "The company explicitly states they are creating a new central group to focus R&D efforts on specific emerging market segments, which is a direct statement about their R&D strategy and resource allocation.",
"context": "Mike Roman's response to Scott Davis's question about R&D productivity, where he explains the company's approach to prioritizing R&D investments in high-growth market segments. He states they are 'putting in place a central group to really focus some of the capabilities that we have in broad material science going after some emerging market segments like climate tech and industrial automation, sustainable packaging.'",
"statement": "We are putting in place a central group to really focus some of the capabilities that we have in broad material science going after some emerging market segments like climate tech and industrial automation, sustainable packaging.",
"topic": "R&D"
}
] |
[] |
[] |
[
{
"analysis": "The company explicitly states its commitment to continue investing in research and development efforts to support innovation in core business areas and new markets.",
"context": "Looking back, in a year full of change, I am pleased how 3Mers around the world stepped-up to lead. Importantly, we stayed relentlessly focused on doing what 3M does best, using material science to make a difference in the world. I see exciting examples of innovation across our company. Earlier this month, we unveiled the world's first solar powered communications headset, building on our decades of leadership in both personal safety and sustainability. We are advancing more durable, energy efficient and connected vehicles with an array of solutions, including new thermal barrier materials that improve the range and safety of electric car batteries, just one element of our automotive electrification program, which grew 30% in 2023, on top of 30% growth in 2022. Our Medical Solutions business, a world leader in advanced wound care, just announced a partnership with the U.S. Army, where we will collaborate with the military and leading universities to develop traumatic wound solutions. And in Consumer, last year, we launched more than a dozen new products, including new solutions for heavyweight hanging, part of our $0.5 billion Command franchise, which leverages our world-class adhesives technology. 3M's innovation engine is strong. It will remain the heart of our business and our ability to deliver differentiated value for our customers.",
"source": null,
"statement": "We will continue to invest in R&D and capital expenditures, enabling us to win in our core and also in new attractive markets where 3M can make a difference.",
"topic": "R&D"
}
] |
[] |
[
{
"analysis": "This statement directly discusses 3M's R&D investment levels, noting that core R&D spending has remained flat over five years and decreased in real terms due to strategic focus on healthcare business strengthening.",
"context": "Bill Brown discusses the company's R&D investment patterns, explaining that while R&D investment is about $1 billion annually (4.5% of revenue), it has been flat over five years and decreased in real terms as the company focused on strengthening the healthcare business. He notes this has contributed to declining new product introductions.",
"statement": "ex- Solventum R&D investment for core 3M, which is running about $1 billion per year, or about 4.5% of revenue, has been flattened nominally over the past five years and down on a real basis as the focus was on investing in and strengthening the healthcare business.",
"topic": "R&D"
},
{
"analysis": "This statement explains that new product development investment has decreased as the company redirected R&D funds toward PFAS exit efforts and supply chain cost reduction, resulting in fewer new products.",
"context": "Bill Brown explains that the company has reduced investment in new product development by shifting R&D dollars to PFAS exit efforts and supply chain cost reduction, resulting in a decline in new product introductions over the past decade. This is part of the company's strategy to address operational challenges.",
"statement": "Within the lower spend, the amount we invest on new product development has declined even further as the company shifted more dollars to efforts to exit PFAS manufacturing and work to reduce supply chain cost and resolve COVID related sourcing constraints.",
"topic": "R&D"
},
{
"analysis": "This statement highlights the significant decline in new product introductions from over 1,000 annually to less than 150, indicating a major reduction in R&D output and innovation capacity.",
"context": "Bill Brown compares current new product introductions (75-76 in first half of year, expected to be less than 150 for the year) to historical levels where the company once launched over 1,000 new products annually. He notes this decline is part of the reason for stagnant organic growth.",
"statement": "The first half of this year we launched about 75, 76 new product introductions. This year we'll do probably less than 150. And as I reflect back over the last eight or nine, 10 years, at one point in time we did over 1000.",
"topic": "R&D"
},
{
"analysis": "This statement identifies specific R&D improvements the company plans to make, focusing on increasing engineering team capacity and accelerating the new product development process.",
"context": "Bill Brown discusses R&D improvements he's working on, including driving effective capacity of the engineering team and increasing velocity through the new product development pipeline. He emphasizes this is essential to reinvigorating 3M's innovation machine.",
"statement": "I think there's an opportunity to drive effective capacity of our engineering team. I think we have an opportunity to drive velocity through the new product development pipeline.",
"topic": "R&D"
},
{
"analysis": "This statement describes the company's plan to restructure R&D governance to optimize investment allocation for maximum ROI across the organization.",
"context": "Bill Brown discusses his approach to R&D, emphasizing the need to rethink governance to ensure R&D dollars are allocated to the highest ROI opportunities across the company. He believes this will improve R&D effectiveness and drive innovation.",
"statement": "We have an opportunity to think differently and how we govern differently on R&D, where we place our precious dollars so that they can move across the company to the highest ROI investment.",
"topic": "R&D"
},
{
"analysis": "The statement directly references the company's plan to reinvigorate its New Product Introduction (NPI) engine, a core R&D process responsible for bringing new products to market, to drive future growth and margin improvements.",
"context": "Andrew Kaplowitz: ... is it particularly challenging to price in that segment? William Brown: ... The other point you had mentioned about new product development, you're exactly right. Which is as we innovate and develop differentiating features, we should be able to get better margin and better pricing on those new products that are coming out. So as we reinvigorate the NPI engine, which I expect to do, hopefully that does drive price improvement, margin improvement, over time as well.",
"statement": "So as we reinvigorate the NPI engine, which I expect to do, hopefully that does drive price improvement, margin improvement, over time as well.",
"topic": "R&D"
}
] |
[
{
"analysis": "This describes specific R&D process improvements to increase efficiency and speed of product development by reducing administrative tasks and improving pipeline velocity.",
"context": "We are fast-tracking projects for low-risk product line extensions eliminating non-value-added activity from our engineers' workload by offloading or outsourcing administrative tasks and increasing pipeline velocity through efforts as simple as reducing the time to setup an SKU from 100 days on average last year to about 60 days this year.",
"statement": "We are fast-tracking low-risk product line extensions, eliminating non-value-added activity from engineers' workloads and increasing pipeline velocity by reducing SKU setup time from 100 to 60 days.",
"topic": "R&D"
},
{
"analysis": "This describes capital allocation specifically for R&D infrastructure improvements to enhance product development capabilities and address bottlenecks.",
"context": "And to address bottlenecks and drive productivity in the product development process, we are shifting capital spending within our existing budget to fund upgrades of R&D facilities to allow us to scale rapidly from lab to pilot to manufacturing.",
"statement": "We are shifting capital to fund R&D facility upgrades to scale rapidly from lab to pilot to manufacturing, addressing bottlenecks in product development.",
"topic": "R&D"
},
{
"analysis": "This describes specific R&D personnel reallocation to focus on new product development in key strategic areas, including adding engineers to priority markets.",
"context": "And finally, we are shifting about 100 people within R&D to focus on new product development, including those who are rolling off PFAS-related projects and adding more than 50 new engineers in the fourth quarter to high priority focus areas such as specialty materials and films for the automotive, aerospace, electronics and semiconductor markets.",
"statement": "We are shifting about 100 people within R&D to focus on new product development, including adding more than 50 new engineers in high priority focus areas.",
"topic": "R&D"
},
{
"analysis": "This states a specific metric related to R&D output, indicating improvement in new product introductions after a prolonged decline.",
"context": "After a decade-long slide in new product introductions, we bottomed out and are starting to turn the corner with new product launches expected to be up about 10% this year with a further acceleration next year.",
"statement": "New product launches are expected to increase by about 10% this year with further acceleration next year, after a decade-long slide.",
"topic": "R&D"
},
{
"analysis": "This directly states progress in R&D effectiveness and efficiency, which are key R&D metrics, and mentions improving the fundamentals of R&D processes.",
"context": "we are beginning to make progress on both R&D effectiveness and efficiency. A lot of our recent efforts have focused on the basic blocking and tackling and improving the fundamentals of our R&D and commercialization processes.",
"statement": "We are beginning to make progress on both R&D effectiveness and efficiency, improving the fundamentals of R&D and commercialization processes.",
"topic": "R&D"
},
{
"analysis": "This describes a specific action to improve R&D process management through better visibility on product development investments across the enterprise.",
"context": "We have taken actions to improve enterprise-wide visibility on specific investments in our product development pipeline.",
"statement": "We have taken actions to improve enterprise-wide visibility on specific investments in our product development pipeline.",
"topic": "R&D"
},
{
"analysis": "This describes process improvements in the R&D and commercialization phase, specifically around product launch management and accountability.",
"context": "We are driving new rigor and discipline into product launch calendars and raising accountability for post-launch sales performance.",
"statement": "We are driving new rigor and discipline into product launch calendars and raising accountability for post-launch sales performance.",
"topic": "R&D"
},
{
"analysis": "This statement directly addresses strategic allocation of R&D budget, indicating a focus on optimizing where the company invests its research resources.",
"context": "Andy Kaplowitz: Could you give us a little more color into your consumer business? I think you talked about that it's getting a bit better. Could you elaborate on what you are seeing there is I think that business tends to be first-in first-out in the historical cycles. And I know you are focused on pricing in that segment, maybe that segment could be the most competitive in terms of pricing. Can you make the pricing improvement you need in that segment?\nBill Brown: So, on consumer, we were down about 3% in the first half, down about 70 basis points in the third quarter. But keep in mind, it has about 230 basis points of headwind associated with some of the portfolio prioritization efforts that the team is working on. And if you go back Q1 to Q2 to Q3 and then head into Q4, it's becoming less negative in terms of organic growth and it's trending to perhaps be positive in the fourth quarter. For the full year, down low-single digits, for the overall, it's mostly a USAC business, a USAC retail business. So, USAC retail sales is down about 50 basis points, for the year, down about 80 basis points. So, it's sort of trending in that – in the line with where USAC retail sales happen to be. When you look at the parts of the portfolio in the quarter, we had pretty good growth in our Command Strips home improvement. The Command Strip business, that was up is partly due to some new product introductions in that space and that they are performing pretty well there. The other the parts of the portfolio were a bit weaker, were flat to down. So, they offset the positive trend in home improvement. But we see good improvement trends going into the fourth quarter. It all depends upon what happens in holiday season as we get through the next couple of months. But the trend line is moving up in terms of its organic growth rate.\nAndy Kaplowitz: Helpful. And then Bill, maybe just stepping back, you have talked a lot about growth through innovation. But how far are you pushing 3M as to focus their innovation on maybe what I would call the right markets because it strikes me that there are just a few big global markets that are driving growth right now.\nBill Brown: So, yes, we are spending a lot of time thinking about where we spend our precious $1 billion in R&D for sure, and making sure it's going after the right areas as part of our overall governance process and how we are developing our strategic plan. To focus on those markets where we have a right to win, where we can actually earn value, we have a strong return on investment in the spaces. And look, the team is pushing on this, and this is a big focus of mine, a big focus of the team.",
"statement": "We are spending a lot of time thinking about where we spend our precious $1 billion in R&D for sure.",
"topic": "R&D"
},
{
"analysis": "This statement describes a strategic shift in R&D budget allocation toward new product development, indicating a renewed focus on innovation.",
"context": "Brett Linzey: Alright. Makes sense. And then just a follow-up on NPA and the launching of the new products, 10% growth next year. Just wanted to better understand the associated costs and where those introductions are aimed at the segment level. Should we be thinking of a commensurate level of R&D step-up, or are you able to achieve this with repurposing the spending base?\nBill Brown: No. So, it's within the existing spending base. As we go into '25, we will come back and talk more about where we see R&D. But a couple of things were happening. One is just it's a shift within where we spend our R&D. Really, it comes in kind of three buckets. I mean, it's about a third that goes into corporate research, longer term horizon things, basic technologies, there is kind of a third that's incremental line extensions, new product introductions. There is a third that that's going after cost reduction, PFAS fixes all those kinds of things. So, there is going to be some shift that's going on between those pieces. That middle bucket used to be around 40%, it dropped below 30%, that piece is coming back up. It's now above – it's now around a third around 32%, 33%. But that middle bucket on new products, new product line extensions is where we are shifting money to drive new product introductions.",
"statement": "That middle bucket used to be around 40%, it dropped below 30%, that piece is coming back up.",
"topic": "R&D"
},
{
"analysis": "This statement reports on current R&D output (new product introductions) and future expectations, indicating improved R&D effectiveness and strategic focus.",
"context": "Brett Linzey: Alright. Makes sense. And then just a follow-up on NPA and the launching of the new products, 10% growth next year. Just wanted to better understand the associated costs and where those introductions are aimed at the segment level. Should we be thinking of a commensurate level of R&D step-up, or are you able to achieve this with repurposing the spending base?\nBill Brown: No. So, it's within the existing spending base. As we go into '25, we will come back and talk more about where we see R&D. But a couple of things were happening. One is just it's a shift within where we spend our R&D. Really, it comes in kind of three buckets. I mean, it's about a third that goes into corporate research, longer term horizon things, basic technologies, there is kind of a third that's incremental line extensions, new product introductions. There is a third that that's going after cost reduction, PFAS fixes all those kinds of things. So, there is going to be some shift that's going on between those pieces. That middle bucket used to be around 40%, it dropped below 30%, that piece is coming back up. It's now above – it's now around a third around 32%, 33%. But that middle bucket on new products, new product line extensions is where we are shifting money to drive new product introductions. The number of new product introductions this year in '24 is up 10% over last year, and we expect that, that 10% will accelerate in 2025 through those pieces I just mentioned a couple of minutes ago.",
"statement": "The number of new product introductions this year in '24 is up 10% over last year, and we expect that, that 10% will accelerate in 2025.",
"topic": "R&D"
}
] |
[
{
"analysis": "This statement describes a specific product (EBO connector) designed for data centers, directly related to computing infrastructure and data center technology.",
"context": "Reinvigorating the innovation engine is critical to sustain this top-line momentum. In 2024, we launched 169 new products, up 32% over the prior year. This was above expectations due in part to the rigor and governance we've put in place around new product introductions, but more importantly, to the enthusiasm of the team to get back to innovating for our customers. One launch we're particularly excited about is our LCD 2.0 platform program that enables LCD displays for tablets, notebooks and monitors to achieve the brightness and contrast similar to OLED, combining our multilayer optical film technology with our microreplication technology. Another one is our Expanded Beam Optics or EBO connector, which is an optical interconnect designed for data centers that reduces installation time, cleaning, and maintenance while delivering exceptional performance.",
"statement": "Another one is our Expanded Beam Optics or EBO connector, which is an optical interconnect designed for data centers that reduces installation time, cleaning, and maintenance while delivering exceptional performance.",
"topic": "Compute Infra"
},
{
"analysis": "This statement directly reports on the company's R&D output, specifically the number of new products launched in 2024, which is a key R&D performance metric.",
"context": "Reinvigorating the innovation engine is critical to sustain this top-line momentum. In 2024, we launched 169 new products, up 32% over the prior year. This was above expectations due in part to the rigor and governance we've put in place around new product introductions, but more importantly, to the enthusiasm of the team to get back to innovating for our customers.",
"statement": "In 2024, we launched 169 new products, up 32% over the prior year.",
"topic": "R&D"
},
{
"analysis": "This statement describes the company's direct investment in R&D staffing, showing commitment to expanding R&D capabilities.",
"context": "Bill Brown: So, good morning, Jeff. Thanks for the question. Yes, we were very pleased with the acceleration of new product introductions, as I mentioned in my remarks, came in above expectations, in fact, quite a bit above the expectations. But still very early. A lot of the products that we're launching are what we call Class III, so they're incremental. So year one sales on these products are going to be somewhat light and it will grow over time over the next several years. More importantly, as we grow our NPI launches next year by double-digit, we shift to more what I call higher octane or Class IV type products, which have more sales capability. We'd likely see more impact on the top-line from these launches. It's an important dimension. I think the team has built momentum. It's part of the governance process. It's a lot of -- it's the enthusiasm, the team. Some of it is shifting some resources around. We added 50 people in Q4 and we moved about another 100 people into R&D development in the quarter. So we're on the right track.",
"statement": "We added 50 people in Q4 and we moved about another 100 people into R&D development in the quarter.",
"topic": "R&D"
},
{
"analysis": "3M describes reallocating capital budget toward R&D investments in lab and prototype equipment to accelerate innovation and product development cycles.",
"context": "Deane Dray: ... And how do you feel about that longstanding policy at 3M R&D where the senior scientists get 15% of unbudgeted time? Does that still fit into the equation? Thanks.\n\nBill Brown: Yes. Look, so 15% of time is sort of a hallmark of the company. ... We are shifting within our capital budget, more investment to R&D for lab equipment, for prototype equipment to speed up the prototyping and scaling up of innovation. We are adding resources there.",
"statement": "We are shifting within our capital budget, more investment to R&D for lab equipment, for prototype equipment to speed up the prototyping and scaling up of innovation.",
"topic": "R&D"
}
] |
[] |
AOS
|
A. O. Smith
|
Industrials
|
Building Products
| 91,142
|
[
{
"analysis": "The statement describes the company's R&D activities, locations, and purpose to improve competitiveness through new products and processes.",
"context": "RESEARCH AND DEVELOPMENT\nTo improve our competitiveness by generating new products and processes, we conduct research and development at our Corporate Technology Center in Milwaukee, Wisconsin, our Global Engineering Center in Nanjing, China, and our operating locations. Our total expenditures for research and development in 2022, 2021 and 2020 were $89.0 million, $94.2 million and $80.7 million, respectively.",
"statement": "To improve our competitiveness by generating new products and processes, we conduct research and development at our Corporate Technology Center in Milwaukee, Wisconsin, our Global Engineering Center in Nanjing, China, and our operating locations.",
"topic": "R&D"
},
{
"analysis": "The statement provides specific financial data on the company's R&D spending over three years.",
"context": "RESEARCH AND DEVELOPMENT\nTo improve our competitiveness by generating new products and processes, we conduct research and development at our Corporate Technology Center in Milwaukee, Wisconsin, our Global Engineering Center in Nanjing, China, and our operating locations. Our total expenditures for research and development in 2022, 2021 and 2020 were $89.0 million, $94.2 million and $80.7 million, respectively.",
"statement": "Our total expenditures for research and development in 2022, 2021 and 2020 were $89.0 million, $94.2 million and $80.7 million, respectively.",
"topic": "R&D"
},
{
"analysis": "This statement directly reports the company's R&D expenditure costs for the past three years, providing specific financial data on their research and development activities.",
"context": "1. Organization and Significant Accounting Policies (continued)\n\nResearch and development. Research and development costs are charged to operations as incurred and amounted to $89.0 million, $94.2 million and $80.7 million during 2022, 2021 and 2020, respectively. This section describes the company's accounting policy for R&D expenses and provides specific financial figures for the past three years, showing their R&D spending patterns.",
"statement": "Research and development costs are charged to operations as incurred and amounted to $89.0 million, $94.2 million and $80.7 million during 2022, 2021 and 2020, respectively.",
"topic": "R&D"
}
] |
[
{
"analysis": "This statement directly describes the company's R&D activities, locations, and purpose, making it relevant to the R&D topic.",
"context": "The statement appears in the 'RESEARCH AND DEVELOPMENT' section of the document, which states: 'To improve our competitiveness by generating new products and processes, we conduct research and development at our Corporate Technology Center in Milwaukee, Wisconsin, our Global Engineering Center in Nanjing, China, and our operating locations. Our total expenditures for research and development in 2023, 2022 and 2021 were $97.5 million, $89.0 million and $94.2 million, respectively.'",
"statement": "To improve competitiveness through new products and processes, we conduct R&D at our Corporate Technology Center in Milwaukee, Global Engineering Center in Nanjing, and operating locations.",
"topic": "R&D"
},
{
"analysis": "This statement directly reports the company's R&D expenses over three years, indicating their ongoing R&D efforts and investment in research.",
"context": "1. Organization and Significant Accounting Policies\nResearch and development. Research and development costs are charged to operations as incurred and amounted to $97.5million, $89.0million and $94.2million during 2023, 2022 and 2021, respectively.",
"statement": "Research and development costs are charged to operations as incurred and amounted to $97.5million, $89.0million and $94.2million during 2023, 2022 and 2021, respectively.",
"topic": "R&D"
},
{
"analysis": "This statement specifies the depreciation period for software assets, indicating the company's accounting treatment of software as a capital asset with a specific useful life.",
"context": "Property, plant and equipment. Property, plant and equipment are stated at cost. Depreciation is computed primarily by the straight-line method. The estimated service lives used to compute depreciation are generally 25 to 50 years for buildings, three to 20 years for equipment and three to 15 years for software.",
"statement": "The estimated service lives used to compute depreciation are generally 25 to 50 years for buildings, three to 20 years for equipment and three to 15 years for software.",
"topic": "Software"
}
] |
[
{
"analysis": "This statement directly describes A. O. Smith's R&D spending over the past three years, providing specific figures for their research and development expenditures.",
"context": "RESEARCH AND DEVELOPMENT\nTo improve our competitiveness by generating new products and processes, we conduct research and development at our Corporate Technology Center in Milwaukee, Wisconsin, our Global Engineering Center in Nanjing, China, and our operating locations. Our total expenditures for research and development in 2024, 2023 and 2022 were $101.7 million, $97.5 million and $89.0 million, respectively.",
"context_length": null,
"statement": "Our total expenditures for research and development in 2024, 2023 and 2022 were $101.7 million, $97.5 million and $89.0 million, respectively.",
"topic": "R&D"
},
{
"analysis": "This statement describes the company's organizational structure for managing their compute infrastructure, specifically the role responsible for protecting their networks and systems.",
"context": "Our Senior Director of Global Information Security (ISD) reports to our CIO and is responsible for the protection and defense of our networks and systems and managing cybersecurity risk. He has over 20 years of experience in managing cybersecurity and related risks, including threat identification, incident response, and defense strategies.",
"context_length": null,
"statement": "Our Senior Director of Global Information Security (ISD) reports to our CIO and is responsible for the protection and defense of our networks and systems and managing cybersecurity risk.",
"topic": "Compute Infra"
},
{
"analysis": "This statement directly reports the company's R&D spending over the last three years, providing specific financial figures for their research and development activities.",
"context": "1. Organization and Significant Accounting Policies (continued)\n\nResearch and development. Research and development costs are charged to operations as incurred and amounted to $ 101.7million, $ 97.5million and $ 89.0million during 2024, 2023 and 2022, respectively.",
"context_length": null,
"statement": "Research and development costs are charged to operations as incurred and amounted to $101.7 million, $97.5 million and $89.0 million during 2024, 2023 and 2022, respectively.",
"topic": "R&D"
}
] |
[] |
[] |
[] |
[] |
[] |
[] |
[
{
"analysis": "This statement directly indicates the company increased its R&D spending, which contributed to higher SG&A expenses in Q1 2024 compared to Q1 2023.",
"context": "Selling, general, and administrative (SG&A) expenses in the first quarter of 2024 increased by $5.0 million compared to the first quarter of 2023. The increase in SG&A expenses in the first quarter of 2024 compared to the prior year period was primarily due to higher research and development expenses and higher employee costs from increased wages and management incentives.",
"statement": "The increase in SG&A expenses in the first quarter of 2024 compared to the prior year period was primarily due to higher research and development expenses.",
"topic": "R&D"
},
{
"analysis": "This statement directly identifies an increase in research and development expenses as a key factor in the company's higher SG&A expenses for the quarter.",
"context": "Selling, general, and administrative (SG&A) expenses in the first quarter of 2024 increased by $5.0 million compared to the first quarter of 2023. The increase in SG&A expenses in the first quarter of 2024 compared to the prior year period was primarily due to higher research and development expenses and higher employee costs from increased wages and management incentives.",
"statement": "The increase in SG&A expenses in the first quarter of 2024 compared to the prior year period was primarily due to higher research and development expenses and higher employee costs from increased wages and management incentives.",
"topic": "R&D"
}
] |
[] |
[] |
[] |
[] |
[
{
"analysis": "This statement explicitly identifies innovation and new product development as a strategic priority for the company, directly relating to R&D efforts.",
"context": "As I mentioned on our January call, one of our key strategic priorities in 2022 is to expand our water treatment business through innovation, new product development and strategic acquisitions. In May, we launched our redesigned Aquasana Clean Water machine. The first power countertop water filter to combine a sleek compact no install design with four different methods of advanced filtration technology. The new clean water machine is tested and certified to NSF standards for the removal of up to 99.9% of 77 contaminants including lead, the forever chemicals, such as PFAS and many more. Aquasana is patented Claryum filtration ensures industry leading contaminant removal while we retaining the beneficial and naturally occurring minerals in water such as calcium, magnesium, and potassium for optimal hydration. In addition, we welcome Atlantic Filter Corporation to the A. O. Smith family last month. Atlantic Filter is the fifth acquisition we've made in the North America water treatment market since 2016. With a strong presence in Southern Florida, Atlantic Filter will expand our capabilities in this key area of the market.",
"statement": "As I mentioned on our January call, one of our key strategic priorities in 2022 is to expand our water treatment business through innovation, new product development and strategic acquisitions.",
"topic": "R&D"
},
{
"analysis": "This statement directly mentions 'investing in technology to drive innovation and new product development,' which is a clear reference to R&D activities.",
"context": "We have premium brands and leading share positions in our major product categories. We estimate replacement demand represents 80% to 85% of US water heater and boiler volumes. The strength of our balance sheet and free cash flow generation support our ability to continue investing for the long term and automation, innovation, new products and acquisitions, as well as returning cash to shareholders, even in times of economic uncertainty. As we have demonstrated throughout our long history, we're able to be successful in all economic cycles. We are focused on meeting the needs of our customers. Our portfolio of strong brands, combined with the investing in technology to drive innovation and new product development, further enhance our market leadership.",
"statement": "Our portfolio of strong brands, combined with the investing in technology to drive innovation and new product development, further enhance our market leadership.",
"topic": "R&D"
}
] |
[] |
[] |
[] |
[] |
[] |
[
{
"analysis": "Direct statement about the company's commitment to R&D investment as part of its capital allocation strategy.",
"context": "From slide 12: 'The strength of our balance sheet allows us to continue to invest in ourselves through research and development and capital expansion while pursuing strategic acquisitions. Earlier this month, our board approved our next quarterly dividend of $0.32 per share. We have increased our dividend for over 30 consecutive years. We repurchased approximately 4.4 million shares of common stock in 2023 for a total of $307 million. We continue our strong track record of delivering return to shareholders.'",
"source": null,
"statement": "The strength of our balance sheet allows us to continue to invest in ourselves through research and development and capital expansion while pursuing strategic acquisitions.",
"topic": "R&D"
},
{
"analysis": "Specific mention of ongoing investment in R&D infrastructure at particular locations.",
"context": "From Q&A session: 'We continue to have kind of a balanced approach. I talked a little bit earlier about investing in ourselves, which are some of the three major expansion projects that we have going on with building manufacturing capabilities for gas tankless for investing in commercial high efficiency capacity, and then continue to invest in our R&D facilities in Lebanon, Tennessee. So we continue to make sure we're doing the right things to invest in ourselves and have three major projects going on.'",
"source": null,
"statement": "we're continuing to invest in R&D facilities in Lebanon, Tennessee.",
"topic": "R&D"
}
] |
[
{
"analysis": "The company is expanding a lab and engineering test facility specifically to support R&D and product innovation efforts in their commercial water heater and boiler markets.",
"context": "Finally, in support of our R&D and product innovation within our commercial water heater and boiler markets, we have initiated the expansion of our Lebanon, Tennessee commercial lab and engineering test facility. The state-of-the-art facility will combine our commercial water heating engineering expertise under one roof and allow for cross-functional collaboration, particularly with mutual technologies like heat pump.",
"statement": "In support of our R&D and product innovation within our commercial water heater and boiler markets, we have initiated the expansion of our Lebanon, Tennessee commercial lab and engineering test facility.",
"topic": "R&D"
}
] |
[] |
[
{
"analysis": "This statement describes progress on a new commercial product development center, which is an R&D facility designed to enhance product development and testing capabilities.",
"context": "I'm now on slide six. As we have discussed earlier this year, we commenced several expansion projects in 2024 to support our long-term growth strategy. We recently celebrated the grand opening of our new facility on our campus in Juárez where we will manufacture gas tankless water heaters for North America. While there is still startup work to be completed, production is expected to begin in early 2025 with the ramp up through the year. We have also added additional heat pump capacity on the same site in support of increased demand for our residential heat pump water heaters. Also, we have made progress on our new state of the art commercial product development center, which is located on the same site as our Lebanon, Tennessee facility.",
"statement": "We have made progress on our new state of the art commercial product development center, which is located on the same site as our Lebanon, Tennessee facility.",
"topic": "R&D"
},
{
"analysis": "The statement describes the company's ongoing R&D activities focused on cost reduction through product innovation and process improvements, directly relating to research and development efforts.",
"context": "In China, when we're looking at China, we have really two pieces. One is we're always looking at cost reduction. It's part of our process and it's part of our process through looking at product innovation, redesigning product to take cost out, process improvement in the plant. So that's an ongoing process along with that ongoing process, particularly since COVID is looking at the efficiencies of our store footprint, looking to streamline and improve the efficiencies and what we support for retail outlets.",
"statement": "product innovation, redesigning product to take cost out, process improvement in the plant.",
"topic": "R&D"
}
] |
[
{
"analysis": "This statement describes a specific investment in a commercial R&D testing and lab facility, which is a research and development infrastructure investment focused on water heating and boiler innovation.",
"context": "We are on schedule to introduce two additional tankless products to round out the product line in the first half of 2025. While there is a headwind to profitability today as we launched with production in China and then transfer production to Juarez, Mexico, we firmly believe that our gas tankless product line sets us up for long-term success in this product category. Also, our near-completed investment in a world-class commercial R&D testing and lab facility in Lebanon, Tennessee. The new center will house our commercial water heater and boiler engineers, where they will focus on the continued innovation of our commercial water heating and boiler portfolio. And finally, our ongoing manufacturing capacity investments to serve the market as regulatory changes in federal, state and local incentives drive demand higher for specific technologies.",
"statement": "Also, our near-completed investment in a world-class commercial R&D testing and lab facility in Lebanon, Tennessee.",
"topic": "R&D"
},
{
"analysis": "The company explicitly states deployment of its enterprise resource planning (ERP) system, which falls under enterprise software implementation as part of IT infrastructure.",
"context": "Second one is on the IT technology side. We've built and deployed our ERP system over the last few years. And that's also an area I have some experience as a previous employer, I led the implementation of their ERP system. And I think we're at the phase now about how do we get value out of both the IT investments we've made. And then it's also a space where technology is moving quite quickly. And how do we just position ourselves for where technology is going to be more competitive as a company.",
"statement": "We've built and deployed our ERP system over the last few years.",
"topic": "Software"
}
] |
[
{
"analysis": "This statement describes the opening of a new R&D facility focused on product development and engineering for commercial water heating and boilers.",
"context": "We have confidence in our ability to navigate the volatile 2025 macro environment. Our leadership position in all the markets that we serve, the stable recurring revenue provided by our core water heater and boiler businesses and our strong balance sheet allow us to continue to invest in ourselves, make attractive strategic acquisitions and maximize shareholder return even in times of uncertainty. As always, we are in close communication with our suppliers, customers and other stakeholders as we navigate the challenging environment. We are deploying diligent cost management actions across our businesses to ensure that we maximize profitability during this time of cost volatility. We are committed to leading the industry forward and are confident that we will continue to build our long history of innovation and proven ability to drive profitable growth. With that, we conclude our prepared remarks and we are now available for your questions. During the quarter, we also cut the ribbon and opened our world class commercial R&D testing Lab facility in Lebanon, Tennessee.",
"statement": "During the quarter, we also cut the ribbon and opened our world class commercial R&D testing Lab facility in Lebanon, Tennessee.",
"topic": "R&D"
}
] |
ABT
|
Abbott Laboratories
|
Health Care
|
Health Care Equipment
| 1,800
| [{"analysis":"This statement provides specific R&D expenditure figures for three consecutive years, (...TRUNCATED)
| [{"analysis":"This statement directly reports the company's R&D expenses over three years, providing(...TRUNCATED)
| [{"analysis":"This statement directly describes Abbott's commitment to research and development effo(...TRUNCATED)
| [{"analysis":"Directly discusses Abbott's R&D spending increase in the first quarter of 2022, includ(...TRUNCATED)
| [{"analysis":"The statement directly reports an increase in the company's R&D expenses for Q2 2022, (...TRUNCATED)
| [{"analysis":"The statement describes impairment charges related to in-process R&D (IPR&D) assets wi(...TRUNCATED)
|
[] | [{"analysis":"The statement directly reports the company's R&D spending increase, quantifying R&D ef(...TRUNCATED)
| [{"analysis":"The statement describes Abbott accounting for $15 million in in-process research and d(...TRUNCATED)
| [{"analysis":"Directly refers to an in-process research and development asset, indicating ongoing R&(...TRUNCATED)
| [{"analysis":"Directly states R&D expense changes compared to prior year, clearly about research and(...TRUNCATED)
| [{"analysis":"This statement explicitly identifies in-process research and development (IPR&D) as a (...TRUNCATED)
| [{"analysis":"This statement provides a factual update on Abbott's R&D spending, noting an increase (...TRUNCATED)
| [{"analysis":"The statement directly reports the company's R&D investment as a percentage of sales, (...TRUNCATED)
| [{"analysis":"This statement directly discusses Abbott's R&D efforts to advance their pipeline and s(...TRUNCATED)
|
[] | [{"analysis":"Company describes internal R&D efforts for PSA technology, including conducting two de(...TRUNCATED)
|
[] | [{"analysis":"CEO explicitly identifies AI as Abbott's key opportunity for personalization in the Li(...TRUNCATED)
| [{"analysis":"Describes clinical trial results (TRILUMINATE study) supporting product efficacy, dire(...TRUNCATED)
| [{"analysis":"This statement directly discusses Abbott's strategic investment in R&D pipeline and th(...TRUNCATED)
|
[] |
[] | [{"analysis":"This describes Abbott's R&D investment in a new diagnostic system for a new market seg(...TRUNCATED)
| [{"analysis":"Directly references Abbott's R&D activities and location, specifying US-based R&D as p(...TRUNCATED)
| [{"analysis":"This statement explicitly describes the company's investment in R&D activities for exp(...TRUNCATED)
|
ABBV
|
AbbVie
|
Health Care
|
Biotechnology
| 1,551,152
| [{"analysis":"Direct statement about AbbVie's R&D efforts and their potential failure to produce com(...TRUNCATED)
| [{"analysis":"This statement directly describes AbbVie's investment in research and development acti(...TRUNCATED)
| [{"analysis":"This statement describes AbbVie's current investment in R&D and the scope of their cli(...TRUNCATED)
| [{"analysis":"AbbVie reports its share of development costs related to a collaboration with Genentec(...TRUNCATED)
| [{"analysis":"This statement directly describes AbbVie's reliance on ongoing research and developmen(...TRUNCATED)
| [{"analysis":"This statement directly reports AbbVie's research and development spending as part of (...TRUNCATED)
| [{"analysis":"Directly discusses R&D expenses related to acquired intellectual property and developm(...TRUNCATED)
| [{"analysis":"Describes evaluation of a drug candidate (ABBV-552) for development, directly related (...TRUNCATED)
| [{"analysis":"The statement describes AbbVie's shared research and development (R&D) activities and (...TRUNCATED)
| [{"analysis":"The company explicitly states ongoing evaluation of R&D operations for optimization op(...TRUNCATED)
| [{"analysis":"Directly states that research and innovation are fundamental to AbbVie's business mode(...TRUNCATED)
| [{"analysis":"This statement describes AbbVie's ongoing evaluation of its R&D operations to identify(...TRUNCATED)
| [{"analysis":"This statement describes a specific R&D activity (preclinical development) for a thera(...TRUNCATED)
| [{"analysis":"This statement directly addresses the company's R&D pipeline progress and future plans(...TRUNCATED)
| [{"analysis":"Describes AbbVie's R&D efforts in early-stage oncology programs for solid tumors.","co(...TRUNCATED)
| [{"analysis":"This statement describes specific regulatory milestones achieved in the immunology R&D(...TRUNCATED)
| [{"analysis":"Direct statement about AbbVie's increased R&D investment over time, showing commitment(...TRUNCATED)
| [{"analysis":"This statement describes a regulatory milestone achieved through R&D efforts for a dru(...TRUNCATED)
| [{"analysis":"AbbVie mentions using their proprietary 'Alle platform' to improve digital products an(...TRUNCATED)
| [{"analysis":"Directly references AbbVie's research and development programs and their anticipated f(...TRUNCATED)
| [{"analysis":"Directly discusses AbbVie's increased R&D investment and specific pipeline programs it(...TRUNCATED)
| [{"analysis":"This statement directly describes AbbVie's R&D efforts and their commitment to maintai(...TRUNCATED)
| [{"analysis":"This describes a regulatory milestone achieved through R&D efforts, expanding a drug's(...TRUNCATED)
| [{"analysis":"This statement describes positive clinical trial results for a drug (tavapadon) in dev(...TRUNCATED)
| [{"analysis":"This statement describes recent R&D accomplishments with specific drug approvals acros(...TRUNCATED)
| [{"analysis":"This statement describes AbbVie's R&D strategy of expanding its pipeline through strat(...TRUNCATED)
|
ACN
|
Accenture
|
Information Technology
|
IT Consulting & Other Services
| 1,467,373
| [{"analysis":"Directly describes Accenture's adoption of AI (generative AI) and compute infrastructu(...TRUNCATED)
| [{"analysis":"Direct prediction about generative AI's transformative impact on Accenture's business (...TRUNCATED)
| [{"analysis":"Direct statement about Accenture's strategic investment in generative AI to capture ne(...TRUNCATED)
|
[] |
[] | [{"analysis":"This statement describes client demand for AI solutions as part of Accenture's managed(...TRUNCATED)
|
[] |
[] | [{"analysis":"This statement indicates client demand for AI as part of operations transformation, wh(...TRUNCATED)
| [{"analysis":"The statement indicates client demand for AI as part of their operational transformati(...TRUNCATED)
|
[] | [{"analysis":"This statement describes how Accenture's consulting revenue is directly driven by help(...TRUNCATED)
| [{"analysis":"This statement directly discusses Accenture's work with clients on implementing AI sol(...TRUNCATED)
| [{"analysis":"This statement describes Accenture's use of AI and predictive analytics to deliver per(...TRUNCATED)
| [{"analysis":"Directly references AI and automation as key components of a banking transformation so(...TRUNCATED)
| [{"analysis":"Directly identifies Cloud Data and AI as essential components for building a strong di(...TRUNCATED)
| [{"analysis":"Identifies AI as a key technology area driving client strategies and fundamental to Ac(...TRUNCATED)
|
[] | [{"analysis":"Accenture describes using generative AI to automate email processing for a multination(...TRUNCATED)
| [{"analysis":"Directly references growing client interest in generative AI and its role in technolog(...TRUNCATED)
| [{"analysis":"Direct statement about Accenture's leadership position in generative AI and its strate(...TRUNCATED)
| [{"analysis":"Accenture states its leadership position in generative AI and its strategic importance(...TRUNCATED)
| [{"analysis":"Describes Accenture's use of GenAI to deliver cost savings for clients, directly linki(...TRUNCATED)
| [{"analysis":"Reports Accenture's GenAI bookings and revenue growth, directly showing adoption and f(...TRUNCATED)
| [{"analysis":"Directly describes client adoption progression of GenAI from proof-of-concept to large(...TRUNCATED)
|
[] |
ADBE
|
Adobe Inc.
|
Information Technology
|
Application Software
| 796,343
| [{"analysis":"Direct statement about Adobe's AI technology (Adobe Sensei) being used to enhance docu(...TRUNCATED)
| [{"analysis":"Adobe explains their development of proprietary AI foundation models to ensure commerc(...TRUNCATED)
| [{"analysis":"Describes Adobe's strategy for developing proprietary AI foundation models while partn(...TRUNCATED)
| [{"analysis":"This statement describes AI features included in Adobe's Creative Cloud product as par(...TRUNCATED)
| [{"analysis":"This statement describes Adobe's integration of machine learning and artificial intell(...TRUNCATED)
| [{"analysis":"Describes Figma's product as a web-based design platform, which is a type of software.(...TRUNCATED)
| [{"analysis":"This statement directly discusses Adobe's investments in R&D, specifically mentioning (...TRUNCATED)
| [{"analysis":"This statement describes Adobe's software delivery model, specifically mentioning SaaS(...TRUNCATED)
| [{"analysis":"Adobe released Adobe Firefly, a group of creative generative AI models, after Septembe(...TRUNCATED)
| [{"analysis":"This statement describes Adobe's initiative to integrate AI into their products in a r(...TRUNCATED)
| [{"analysis":"Direct statement about Adobe's AI strategy to empower creators with responsible AI imp(...TRUNCATED)
| [{"analysis":"Describes Adobe's generative AI models for creative content creation.","context":"Crea(...TRUNCATED)
| [{"analysis":"This statement refers to Adobe's subscription revenue from its Digital Media and Digit(...TRUNCATED)
| [{"analysis":"This statement directly describes Adobe's use of its AI engine (Adobe Sensei) to enhan(...TRUNCATED)
| [{"analysis":"This statement describes Adobe's R&D investment in AI features for their flagship prod(...TRUNCATED)
| [{"analysis":"Directly addresses how the Figma acquisition will impact Adobe's research and developm(...TRUNCATED)
| [{"analysis":"This statement directly discusses Adobe's generative AI technology being integrated in(...TRUNCATED)
| [{"analysis":"This statement describes Adobe's demonstration of generative AI technology at their MA(...TRUNCATED)
| [{"analysis":"Describes adoption metrics for Adobe's generative AI product Firefly.","context":"Our (...TRUNCATED)
| [{"analysis":"Describes the commercial availability and integration of generative AI capabilities ac(...TRUNCATED)
| [{"analysis":"This statement describes Adobe's strategic approach to investing in AI across data, mo(...TRUNCATED)
| [{"analysis":"Directly describes Adobe's AI feature (Firefly) adoption and usage metrics in its Phot(...TRUNCATED)
| [{"analysis":"Adobe describes their investment in developing and integrating Firefly AI models into (...TRUNCATED)
| [{"analysis":"This statement describes Adobe's specific AI strategy, highlighting their differentiat(...TRUNCATED)
| [{"analysis":"Directly states Adobe's development and introduction of generative AI models as part o(...TRUNCATED)
| [{"analysis":"Adobe views AI as a strategic opportunity to enhance their technology platforms and se(...TRUNCATED)
|
AMD
|
Advanced Micro Devices
|
Information Technology
|
Semiconductors
| 2,488
| [{"analysis":"Directly describes AMD's strategic focus on AI development across multiple computing e(...TRUNCATED)
| [{"analysis":"Directly states AMD's belief in AI's centrality to their products and their roadmap fo(...TRUNCATED)
| [{"analysis":"This statement expresses AMD's strategic view on AI's role in computing and its expect(...TRUNCATED)
| [{"analysis":"This statement describes AMD's announcement of AI-focused technology including the Ins(...TRUNCATED)
| [{"analysis":"This statement directly describes AMD's acquisition of Pensando to enhance capabilitie(...TRUNCATED)
| [{"analysis":"This statement directly describes the company's in-process research and development ac(...TRUNCATED)
| [{"analysis":"This statement describes how AMD's acquisition of Pensando directly expands its comput(...TRUNCATED)
| [{"analysis":"This statement directly reports AMD's R&D expense increase, showing their investment i(...TRUNCATED)
| [{"analysis":"Directly states increased R&D investment in AI as a reason for decreased operating inc(...TRUNCATED)
| [{"analysis":"This statement identifies AI accelerators as a specific product category within AMD's (...TRUNCATED)
| [{"analysis":"Refers to the company's development and product offerings of hardware specifically des(...TRUNCATED)
| [{"analysis":"This statement indicates AMD's product portfolio includes AI Accelerators, which are h(...TRUNCATED)
| [{"analysis":"Refers to AMD's AI accelerator products within their Data Center segment.","context":"(...TRUNCATED)
| [{"analysis":"AMD is launching a new software suite specifically designed for AI applications.","con(...TRUNCATED)
| [{"analysis":"AMD is implementing AI strategy across multiple computing environments including cloud(...TRUNCATED)
| [{"analysis":"This statement directly describes AMD's involvement in the PyTorch Foundation, which i(...TRUNCATED)
| [{"analysis":"Describes the technical foundation of Ryzen AI, AMD's on-chip AI inference engine in p(...TRUNCATED)
| [{"analysis":"Describes AMD's expansion of software ecosystem support for Instinct GPUs, specificall(...TRUNCATED)
| [{"analysis":"AMD's update to ROCm software, a key AI platform, enhances hardware performance for de(...TRUNCATED)
| [{"analysis":"Directly discusses AMD's progress on AI hardware and software road maps and customer m(...TRUNCATED)
| [{"analysis":"Describes AMD's focus on a multi-generational AI accelerator roadmap beyond current pr(...TRUNCATED)
| [{"analysis":"AMD's leadership statement on AI's transformative role in personal computing, emphasiz(...TRUNCATED)
| [{"analysis":"Direct statement about AMD's AI accelerator product revenue performance, specifically (...TRUNCATED)
| [{"analysis":"Directly reports growth in AI accelerator adoption across cloud, OEM, and AI customer (...TRUNCATED)
| [{"analysis":"Directly describes AI hardware performance improvement for the next-generation acceler(...TRUNCATED)
| [{"analysis":"This statement directly describes AMD's progress in AI infrastructure projects for sov(...TRUNCATED)
|
AES
|
AES Corporation
|
Utilities
|
Independent Power Producers & Energy Traders
| 874,761
| [{"analysis":"This statement directly describes Fluence, a joint venture by AES, providing AI-enable(...TRUNCATED)
| [{"analysis":"This statement directly addresses the company's recognition of growing demand for data(...TRUNCATED)
|
[] | [{"analysis":"","context":"","statement":"","topic":""},{"analysis":"The company explicitly states o(...TRUNCATED)
|
[] |
[] |
[] |
[] | [{"analysis":"Mentions investment in new technologies but is too vague to specifically relate to sof(...TRUNCATED)
|
[] |
[] |
[] | [{"analysis":"AES describes strategic investments in Uplight (energy management software) and Maximo(...TRUNCATED)
| [{"analysis":"This statement describes a specific digital platform (Fluence IQ) that is part of Flue(...TRUNCATED)
|
[] |
[] |
[] |
[] | [{"analysis":"This statement directly describes the company's implementation of AI and data analytic(...TRUNCATED)
| [{"analysis":"AES is developing proprietary software for energy efficiency that utilizes AI for grid(...TRUNCATED)
| [{"analysis":"AES states they will pursue AI as an efficiency improvement for their company, indicat(...TRUNCATED)
|
[] | [{"analysis":"This statement describes how generative AI is being used internally to improve efficie(...TRUNCATED)
| [{"analysis":"Directly states AES's role in providing renewable energy specifically for data center (...TRUNCATED)
|
[] |
[] |
AFL
|
Aflac
|
Financials
|
Life & Health Insurance
| 4,977
| [{"analysis":"This statement directly references the company's information technology systems and de(...TRUNCATED)
| [{"analysis":"The statement directly mentions the company's investment in developing and using artif(...TRUNCATED)
| [{"analysis":"Aflac plans to continue investing in AI as part of their digital capabilities and prod(...TRUNCATED)
| [{"analysis":"The statement describes modernizing a technology platform used for actuarial work, whi(...TRUNCATED)
| [{"analysis":"Describes Aflac Japan's use of a proprietary virtual sales tool for online insurance a(...TRUNCATED)
| [{"analysis":"Describes Aflac's efforts to modernize its actuarial technology platform, which involv(...TRUNCATED)
| [{"analysis":"This statement describes Aflac Japan's use of a proprietary virtual sales tool for onl(...TRUNCATED)
| [{"analysis":"Describes Aflac Japan's use of a proprietary virtual sales tool for online consultatio(...TRUNCATED)
| [{"analysis":"The statement describes Aflac Japan's use of a proprietary virtual sales tool for onli(...TRUNCATED)
| [{"analysis":"This statement describes Aflac Japan's use of proprietary software systems for digital(...TRUNCATED)
| [{"analysis":"This statement describes a third-party cloud hosting services agreement, directly rela(...TRUNCATED)
| [{"analysis":"This describes Aflac Japan's proprietary digital platform for insurance applications, (...TRUNCATED)
| [{"analysis":"Describes Aflac's proprietary system for smart device-based insurance applications, fi(...TRUNCATED)
|
[] |
[] |
[] | [{"analysis":"This statement describes Aflac Japan's specific progress in digitalizing their applica(...TRUNCATED)
| [{"analysis":"Describes a proprietary digital platform used to provide cancer policyholder services,(...TRUNCATED)
| [{"analysis":"The company explicitly states efforts to increase digital adoption for business applic(...TRUNCATED)
| [{"analysis":"This statement describes Aflac's strategic focus on digitizing their platform to repla(...TRUNCATED)
|
[] |
[] |
[] |
[] | [{"analysis":"The statement refers to the dental vision platform, a proprietary software system the (...TRUNCATED)
|
[] |
A
|
Agilent Technologies
|
Health Care
|
Life Sciences Tools & Services
| 1,090,872
| [{"analysis":"The statement describes how Agilent's software and service solutions will enable custo(...TRUNCATED)
| [{"analysis":"Direct statement about ongoing R&D investment to maintain competitive position and del(...TRUNCATED)
| [{"analysis":"This statement describes Agilent's software offerings for laboratory applications, spe(...TRUNCATED)
| [{"analysis":"Directly states the company's R&D expense increase and reasons for it.","context":"Res(...TRUNCATED)
| [{"analysis":"This statement indicates Agilent's research and development expenses as part of their (...TRUNCATED)
| [{"analysis":"The company acquired advanced artificial intelligence technology, directly indicating (...TRUNCATED)
| [{"analysis":"This statement directly reports on the company's R&D expenses, showing a 5% increase c(...TRUNCATED)
| [{"analysis":"This describes a specific software product offered by Agilent in their Life Sciences a(...TRUNCATED)
| [{"analysis":"This describes specific software products offered by Agilent in their Life Sciences an(...TRUNCATED)
| [{"analysis":"This statement directly mentions research and development as an area of investment for(...TRUNCATED)
| [{"analysis":"This statement explicitly describes Agilent's specific software products for laborator(...TRUNCATED)
| [{"analysis":"Mentions software as a component of cell analysis business offerings, indicating its i(...TRUNCATED)
| [{"analysis":"This statement describes the company's strategic reorganization of its software and in(...TRUNCATED)
| [{"analysis":"Describes the intended benefits of the acquired AI technology for automating chromatog(...TRUNCATED)
| [{"analysis":"This statement directly refers to the company's investments in research and developmen(...TRUNCATED)
| [{"analysis":"This statement describes the introduction of a specific software product (mass Hunter (...TRUNCATED)
| [{"analysis":"The company explicitly states plans to increase investment in digital and software cap(...TRUNCATED)
|
[] |
[] | [{"analysis":"The company introduced AI software for data analysis as part of new products at the AS(...TRUNCATED)
| [{"analysis":"The statement explicitly describes the company's strategic reallocation of R&D funding(...TRUNCATED)
|
[] |
[] | [{"analysis":"The statement directly describes an acquisition of a company using artificial intellig(...TRUNCATED)
| [{"analysis":"This statement directly predicts that the new organizational structure will accelerate(...TRUNCATED)
| [{"analysis":"This statement directly identifies Agilent's software products (InfinityLab Assist and(...TRUNCATED)
|
End of preview. Expand
in Data Studio
README.md exists but content is empty.
- Downloads last month
- 2